These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10800415)

  • 41. Determination of lung cancer incidence in the elderly using Medicare claims data.
    McBean AM; Babish JD; Warren JL
    Am J Epidemiol; 1993 Jan; 137(2):226-34. PubMed ID: 8452127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.
    Jemal A; Clegg LX; Ward E; Ries LA; Wu X; Jamison PM; Wingo PA; Howe HL; Anderson RN; Edwards BK
    Cancer; 2004 Jul; 101(1):3-27. PubMed ID: 15221985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Completeness of ascertainment by cancer registries: putting bounds on the number of missing cases.
    Silcocks PB; Robinson D
    J Public Health (Oxf); 2004 Jun; 26(2):161-7. PubMed ID: 15284320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new method to evaluate the completeness of case ascertainment by a cancer registry.
    Das B; Clegg LX; Feuer EJ; Pickle LW
    Cancer Causes Control; 2008 Jun; 19(5):515-25. PubMed ID: 18270798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance for Cancer Incidence and Mortality - United States, 2012.
    Singh SD; Henley SJ; Ryerson AB
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 63(55):17-58. PubMed ID: 27736826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer Registration in India - Current Scenario and Future Perspectives.
    Chatterjee S; Chattopadhyay A; Senapati SN; Samanta DR; Elliott L; Loomis D; Mery L; Panigrahi P
    Asian Pac J Cancer Prev; 2016; 17(8):3687-96. PubMed ID: 27644602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer statistics, 2016.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2016; 66(1):7-30. PubMed ID: 26742998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Address at Diagnosis: Place Matters.
    Sherman RL
    J Registry Manag; 2017; 44(2):76-7. PubMed ID: 29611689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving Hospital Reporting of Patient Race and Ethnicity--Approaches to Data Auditing.
    Zingmond DS; Parikh P; Louie R; Lichtensztajn DY; Ponce N; Hasnain-Wynia R; Gomez SL
    Health Serv Res; 2015 Aug; 50 Suppl 1(Suppl 1):1372-89. PubMed ID: 26077950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examination of Preliminary Cancer Surveillance Data from the National Program of Cancer Registries, Diagnosis Year 2012.
    Freeman MBB; Wilson RJ; Ryerson B
    J Registry Manag; 2017; 44(2):62-8. PubMed ID: 29611676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using hospital discharge files to enhance cancer surveillance.
    Penberthy L; McClish D; Pugh A; Smith W; Manning C; Retchin S
    Am J Epidemiol; 2003 Jul; 158(1):27-34. PubMed ID: 12835284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method.
    Hackl M; Waldhoer T
    Eur J Public Health; 2013 Oct; 23(5):889-93. PubMed ID: 23002230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.
    Jemal A; Ward EM; Johnson CJ; Cronin KA; Ma J; Ryerson B; Mariotto A; Lake AJ; Wilson R; Sherman RL; Anderson RN; Henley SJ; Kohler BA; Penberthy L; Feuer EJ; Weir HK
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries.
    Huang L; Midthune D; Krapcho M; Zou Z; Horner MJ; Feuer EJ
    Biom J; 2013 Sep; 55(5):755-70. PubMed ID: 23873707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Legal and practical issues regarding collection and disclosure of prognostic data in population-based cancer registries].
    Tanaka H
    Nihon Koshu Eisei Zasshi; 2006 Jun; 53(6):391-7. PubMed ID: 16881527
    [No Abstract]   [Full Text] [Related]  

  • 57. An Innovative Approach to Improve Completeness of Treatment and Other Key Data Elements in a Population-Based Cancer Registry: A15-Month Data Submission.
    Hsieh MC; Mumphrey B; Pareti L; Yi Y; Wu XC
    J Registry Manag; 2017; 44(2):69-75. PubMed ID: 29611688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive Cancer Incidence and Survival--United States, 2012.
    Henley SJ; Singh SD; King J; Wilson RJ; O'Neil ME; Ryerson AB
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(49):1353-8. PubMed ID: 26678069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States.
    Pappaioanou M; Dondero TJ; Petersen LR; Onorato IM; Sanchez CD; Curran JW
    Public Health Rep; 1990; 105(2):113-9. PubMed ID: 2157233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.